Among hydroxycinnamic acids, caffeic, ferulic and p-coumaric acids have received considerable attention due to their biological activities. However, studies related to the biological activities of o-coumaric acid (OCA) are limited. In this regard, this study was designed to determine the chemopreventive potential of OCA in human breast cancer cells (MCF-7). The EC 50 value of OCA was found to be 4.95 mM and was used throughout the study. Caspase-3 protein and mRNA levels increased by 59% and 72%. Similarly, protein and mRNA levels of Bax were increased by 115% and 152%. However, OCA treatment caused 48% and 35% decreases in Bcl-2 protein and mRNA levels. Cyclin D1 and cyclin dependent kinase-2 protein and mRNA levels decreased significantly. Moreover, p53 protein and mRNA levels increased by 178% and 245%, respectively. In addition to p53, PTEN protein and mRNA levels were induced. Although, CYP1A1, CYP1A2 and CY2E1 mRNA levels increased, CYP3A4 and CYP2C9 mRNA levels decreased in response to OCA treatment. These results suggest that OCA demonstrates anticarcinogenic activity on MCF-7 cells by activating multiple pathways. However, it also has high carcinogen activating and drug interaction potential. Therefore, serious precautions must be taken before using OCA.
Of the hydroxycinnamic acids, caffeic acid, ferulic acid, m-and p-coumaric acids have received much more attention due to their diverse biological activities such as anti-oxidant, anti-fibrosis, antiviral, anti-tumor, and anti-thrombotic activities [8] [9] [10] [11] [12] [13] [14] [15] . On the other hand, studies related to the biological activities of o-coumaric acid (OCA) are limited and there is no report about its anti-carcinogenic activity. In this regard, the present study was undertaken to determine the anti-carcinogenic mechanism of action of OCA in the human breast cancer cell line MCF-7. Moreover, possible carcinogen activating and drug interaction potential of OCA were also thoroughly examined.
The cytotoxicity of OCA in MCF-7 cells was investigated by measuring the cleavage of WST-1 to formazan by metabolically active cells. As shown in Figure 1 , OCA treatment revealed a concentration-dependent cytotoxic effect on MCF-7 cells. The viability of MCF-7 treated cells was reduced by 27.8% and 58.6% after incubation with 2.5 mM and 5 mM OCA, respectively, as compared with untreated control cells. The EC 10 , EC 25 and EC 50 values of OCA were 9.8 mM, 8.05 mM and 4.95 mM, respectively. The EC 50 (4.95 mM) value of OCA was used throughout this study.
The effect of OCA on protein and mRNA levels of apoptotic proteins was determined throughout this study. Relative caspase-3 protein and mRNA levels were increased by 59% and 72% following 24 h of treatment of the MCF-7 cells, respectively ( Figure  2) . Similarly, protein and mRNA levels of bax were increased by 115% and 152% in OCA-treated cells relative to untreated control cells (p<0.05). In contrast, OCA treatment caused 48% and 35% decreases in bcl-2 protein and mRNA levels, respectively (p<0.05).
The effect of OCA on cell cycle progression was also determined throughout this study ( Figure 3 ). As shown in Figure 3 , cyclin D1 protein and mRNA levels were decreased by 48% and 42%, respectively (p<0.05). Similarly, protein and mRNA levels of cyclin dependent kinase-2 (CDK2) were decreased 52% and 65% following 24 h OCA treatment of MCF-7 cells ( Figure 3 ). Moreover, statistically significant 165% and 232% increases in CDKN2A protein and mRNA levels were observed in MCF-7 cells as a result of 24 h treatment with OCA ( Figure 3 ).
In addition to the assessment of the apoptotic and cell cycle regulator proteins, the effect of OCA on the expression of tumor suppressor proteins in MFC-7 cells was also investigated ( Figure 4 ). The p53 protein band intensity was increased by 178% in OCAtreated cells (Figure 4 ). Similarly, p53 mRNA level was increased by 245% following treatment with OCA. In addition to p53, PTEN protein and mRNA levels were induced by 37% and 68%, respectively ( Figure 4 ).
Additionally, the effect of OCA on the expression of the main CYP isozymes participating in both drug and carcinogen metabolism was determined throughout this study ( Figure 5 ). CYP1A1 and CYP1A2 mRNA levels were increased by 70% and 175% in OCA-treated cells relative to untreated control cells, respectively (p<0.05). Similarly, the CYP2E1 mRNA level was increased by 286% following OCA treatment (p<0.05). In contrast to CYP2E1, CYP1A1, CYP1A2, CYP3A4 and CYP2C9 mRNA levels decreased by 75% and 50% in response to OCA treatment, respectively ( Figure 5 ).
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Although research is ongoing for the development of more effective drugs, cancer remains one of the major causes of death. It is well established that natural products (mostly obtained from herbs) are important for providing clues for the identification and development of new cancer therapies. Thus, we have focused on the apoptotic and antiproliferative impact of OCA on human breast cancer cells. This is the first study reporting the in vitro anti-cancer activity of OCA by demonstrating its effect on the key proteins in the apoptotic pathway, cell division and tumor suppression. Moreover, the impact of OCA on xenobiotic metabolism, possible drug interaction and carcinogen activating potential were determined for the first time in MCF-7 cells.
The profile of human exposure to phenolic acids remains complex. Based on the diet, the estimated daily intake of phenolic acids varied between 25 mg to 1 g/day [6, 7] . The OCA concentration used in MCF-7 cells in this study, 4.95 mM (811 g/mL), was within the range of human dietary intake. To our knowledge, there is no literature study on the effect of OCA on protein and mRNA levels of apoptotic proteins in the MCF-7 cell line. As shown in Figure 2 , OCA caused significant induction of caspase-3 and bax protein and mRNA levels. On the other hand, bcl-2 mRNA and protein levels were significantly decreased. It is well established that apoptosis is a tightly regulated cellular process under the control of two pathways, that is, extrinsic and intrinsic pathways. The results of the present work suggest that the apoptotic activity of OCA in MCF-7 cells was associated with intrinsic pathway activation, which was demonstrated by up-regulation of caspase-3 and bax and down regulation of the bcl-2 level. Similar to observations made in the current study, different cancer cells treated with phenolic acids such as ferulic acid, caffeic acid, and p-coumaric acid produced induction of apoptosis [8a-8c, 9a-9d].
Since the loss of strict regulation of the cell cycle is another important hallmark of cancer development, many drugs and bioactive substances are targeted to those proteins involved in cell cycle regulation and are currently used for the treatment of many kinds of cancer. Therefore, major control proteins of the cell cycle, such as cyclins, cyclin-dependent kinases (CDKs) and cyclindependent kinase inhibitors (CDKNs), were investigated in the current study. It was shown that OCA blocked the deregulated cell cycle in MCF-7 cells by inhibiting cyclin D1 and CDK2 and by inducing CDKN2A (Figure 3 ). These results also indicate that OCA inhibits proliferation of MCF-7 cells by inhibiting the cell-cycle at different stages. Similar to our results, phenolic acids, including caffeic acid, ferulic acid and p-coumaric acid, have been shown to block the deregulated cell cycle in several other cancers [9e, 10, 11] . Cyclin D1 has been shown to be overexpressed in breast cancer [12a] . It was shown that some plant substances, such as curcumin, inhibit progression of the cell cycle by down-regulating the expression of cyclin D1 through suppression of NF-kB activity. This resulted in a decrease in the formation of cyclin D1/CDK complex, resulting in suppression of proliferation and induction of apoptosis [12b]. Moreover, it is well known that CDKN2A is an inhibitor of cyclin D and CDKs that initiate the phosphorylation of retinoblastoma (Rb) and arrests cells in the G1 phase. Our results showed that upregulation of CDKN2A and down regulation of cyclin D1 and CDK2 following OCA treatment may cause cell cycle arrest at the G1 phase and Rb and NF-kB may play a role in this arrest. Tumor-suppressor proteins are critical regulators in many cellular processes such as cellular response to DNA-damage, apoptosis, signal transduction and cell cycle control [12c] . For this reason, we have also examined whether OCA caused any alterations in tumor-suppressor proteins, namely p53 and PTEN in MCF-7 cells. As shown in Figure 4 , mRNA and protein levels of both p53 and PTEN were increased by treatment of OCA significantly. These results strongly suggest that increases in the mRNA and protein levels of p53 by OCA treatment might be resulting in the downstream activation of bax, and possibly others, and thereby causing induction of apoptosis and cell cycle arrest. Similar observations have been reported for curcumin and resveratrol treated neuroblastoma cells [13a] .
Despite apoptotic and cell cycle arresting effects, OCA caused induction of CYP1A2 and CYP2E1, which are involved mainly in carcinogen activation. This is the first study to report the effects of OCA on xenobiotic metabolism, possible drug interactions and carcinogen activating potential in a human cancer cell line. Among all the cytochrome P450 isoforms assessed, CYP1A is considered to be the most critical due to its role in the metabolism of carcinogens, mutagens and environmental pollutants. In this study, CYP1A1 and CYP1A2 mRNA levels increased following treatment with OCA ( Figure 5 ). Induction of CYP1A by OCA may stimulate the metabolic breakdown of many carcinogenic and pro-carcinogenic substrates of this enzyme such as aromatic and heterocyclic amines. It was shown that when CYP1A2 was induced by its inducer; such as components of cigarette smoke, carcinogenicity or hepatotoxicity due to heterocyclic amines was increased [13b,13c]. Similar to CYP1A1 and CYP1A2, OCA treatment increased CYP2E1 mRNA levels by 286% ( Figure 5 ). CYP2E1 has received a great deal of attention in recent years because of its vital role in the activation of many low molecular weight toxic chemicals such as benzene, acrylamide, CCl 4 , nitrosamines and pyridine [13d,13e, 14, 15] . It was shown that exposure to a toxic or carcinogenic chemical may result in an increase in toxicity. The observation that ethanol consumption (substrate and inducer of CYP2E1) increased the toxicity of CCl 4 and acetaminophen supports this potentiation [13e]. The results of the present work indicate that OCA can stimulate metabolism of aromatic and heterocyclic amines, N-nitrosodimethylamine, pyridine, benzene and other toxic chemicals that are metabolized by increasing CYP1A and CYP2E1 expression. It may, in turn, result in increased amounts of reactive metabolites formed that could further potentiate the risk of organ toxicity, mutagenesis and malignant transformation in OCA-exposed subjects.
It is well known that CYP3A4 plays a significant role in drug metabolism, with approximately 50% of marketed drugs metabolized by CYP3A4 in humans. It possesses metabolic activity towards an extremely broad spectrum of xenobiotic substrates including antibiotics, anti-arrhythmics, sedatives, immune system modulators, calcium channel blockers, HIV-directed antiviral agents and HMG CoA reductase inhibitors [16] . CYP3A is followed by the CYP2C subfamily that accounts for approximately 20% of the total liver cytochrome P450 content in humans. Hence, the effects of OCA on the expression of CYP3A4 and CYP2C9 mRNA levels were also determined throughout this study. As shown in Figure 5 , CYP3A4 and CYP2C9 mRNA levels decreased by 75% and 50% in response to OCA treatment, respectively. It is well established that modulation of these cytochrome P450 isozymes by plant extracts, chemicals or pathophysiologic situations caused impairment in drug metabolism. Therefore, on the basis of its nondiscriminatory effects on CYP3A and CYP2C enzymes, OCA could in principle affect the actions of many medicines. Moreover, alteration of drug clearance and clinical drug toxicity may be observed due to changes in these CYP isozymes.
In conclusion, based on the observed changes in many proteins, we have shown that OCA is able to show an anti-carcinogenic effect by stimulating different pathways including apoptosis, cell cycle regulation and tumor suppression. Therefore, OCA might be an alternative and complementary agent for the treatment of breast cancer. However, it may stimulate the metabolic breakdown of toxic chemicals metabolized by CYP2E1 and CYP1A2 through increased expression of these isozymes, which consequently may result in increased amounts of reactive metabolite formation. This may in turn further potentiate the risk of toxicity, carcinogenesis, mutagenesis and malignant transformation in these subjects. Therefore, serious precautions should be taken in terms of OCA exposure through diet or supplement. Cell culture: The human breast adenocarcinoma cell line (MCF-7) was obtained from the European Collection of Cell Cultures (ECACC, UK). The cells were cultured in DMEM supplemented by 10% FBS and 1% penicillin/streptomycin mixture in a humidified atmosphere of 95% air with 5% CO 2 at 37°C and were subcultured twice a week.
Cytotoxicity assay: MCF-7 cells were grown in 96-well plates at a density of 1x10 3 cells/mL culture medium. After 24 h pre-exposure incubation, the cells were treated with varying concentrations of OCA between 1 mM and 10 mM. OCA was dissolved in dimethylsulfoxide (DMSO) and the final concentration of DMSO did not exceed 0.1%. The control cultures were also treated with 0.1% DMSO. An equal amount of medium without OCA was added to untreated cells (control). OCA-treated and control cells were incubated for 48 h at 37°C in a humidified 5% CO 2 atmosphere. After 48 h, cell growth was assessed by using WST-l (4-(3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio)-1,3-benzene disulfonate). Briefly, 10 µL WST-l was added to the wells and incubated for 1 h, and then cell growth was assessed by measuring the absorbance at 450 nm. Three replicate wells were used for each experimental condition. Viability was expressed as a percentage of the control.
Cell homogenate preparation: MCF-7 cells (1x10 7 cells per 75 cm 2 flask) were exposed to 4.95 mM OCA and harvested after a 24 h treatment. Cells were then washed twice with PBS and scraped from culture dishes in lysis buffer (0.1 M phosphate buffer Tris-HCl, pH 7.8, 0.2% Triton X-100, 2 mM EDTA, 0.5 mM PMFS, 0.3 mM ε-ACA and 1 mM 1,4-Dithiothreitol (DTT) and homogenized mechanically by sonication. Total cellular protein concentration was determined by BCA assay using BSA as the standard.
Gel electrophoresis and Western blotting: SDS-PAGE and
Western blotting were performed as described previously [17] . MCF-7 total protein was extracted with TRIzol reagent (Invitrogen, USA), as described in [18] . Protein samples (150 μg) were separated on either 8.5% or 12% polyacrylamide gels using the discontinuous buffer system of Laemmli [19] and transferred to nitrocellulose membranes using the iBlot (Invitrogen) dry blotting system (20 V, 12 min) employing iBlot gel transfer stacks. Following transfer, membranes were blocked using 5% non-fat dry milk in TBS-T (20 mM Tris-HCl, pH 7.4, 400 mM NaCl and 0.1%, v/v, Tween-20) for 60 min and incubated with polyclonal antihuman bax, bcl-2, caspase-3, PTEN, CDK2, p53, cyclin D1 and CDKN2A antibodies (diluted 1:200 to 1:1000 in blocking solution) overnight at room temperature. The membranes were then washed with TBST (3 × 5 min), incubated with the secondary antibody (HRP-conjugated secondary antibody at a 1:5000 or 1:10000 dilution) for 60 min and again washed with TBST (3 × 5 min). 
RNA isolation and RT-PCR:
Total RNA was extracted from MCF-7 cells using TRIzol reagent. Extracted RNA was quantified spectrophotometrically at 260/280 nm, and the integrity was checked using a 1% agarose gel. For cDNA synthesis, 2.5 µg of RNA was incubated at 70°C for 10 min with 0.5 µg of oligo(dT). After 5 min on ice, 50 U of Moloney murine leukemia virus reverse transcriptase, 1 mM dNTPs and buffer were added to the previous mixture and incubated at 42ºC for 60 min. The reaction was stopped by heating at 70°C for 10 min, and cDNA was stored at -80°C for further use. A semi-quantitative two-step RT-PCR assay was performed using gene-specific primers (Table 1) . Preliminary control experiments (data not shown) were carried out to verify the RT-PCR conditions that allowed for linear amplification of PCR products. These were analyzed by electrophoresis on 1.5 -2% agarose gels containing ethidium bromide, and the intensity of the bands was measured using Scion Image Version Beta 4.0.2 software. mRNA levels of analyzed genes were determined by measuring the intensity of the RT-PCR product bands on each agarose gel and are reported relative to 18S rRNA expression.
Statistical analysis:
Statistical analyses were performed using the Minitab statistical software package. All results were expressed as means including their Standard Error of Means (SEM). Comparison between groups was performed using Student's t-test, and p< 0.05 was selected as the level required for statistical significance. 
